29 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
16220978	14	Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.	Uppsala University
11960488	3	Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.	Uppsala University
1469703	14	Dihydropyrimidine angiotensin II receptor antagonists.	Bristol-Myers Squibb Pharmaceutical Research Institute
	17	1,4-substituted indoles: a potent and selective class of angiostensin II receptor antagonists	TBA
	8	Acyliminothiadiazoline derivatives: New, highly potent, and orally active angiotensin II receptor antagonists	TBA
	31	Uracil-based angiotensin II receptor antagonists	TBA
	24	Discovery of nonpeptide potent conformationally restricted angiotensin II receptor antagonists	TBA
	12	A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist	TBA
	1	Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonists	TBA
	12	Quinoline-4-carboxylic acids as angiotensin II receptor antagonists	TBA
	16	Dihydro-imidazolone derivatives as angiotensin II receptor antagonists: chiral effect on the activity	TBA
	6	Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonists	TBA
	19	Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamide	TBA
15115399	41	Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.	Università
12190306	14	Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.	Bristol-Myers Squibb Pharmaceutical Research Institute
8510101	37	Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.	Warner-Lambert
8496939	100	Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.	Merck Research Laboratories
8421274	27	Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.	Searle
8340920	43	Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists.	Searle R&D
8258826	42	6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.	Dr. Karl Thomae
8230127	52	A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.	Sanofi Recherche
8201597	10	Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives.	E. Merck
8057285	44	Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists.	Carpibem
1920360	13	Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.	Ciba-Geigy
1635064	8	Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity.	Eli Lilly
1433195	55	Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.	Smithkline Beecham Pharmaceuticals
1433184	7	Discovery of a novel class of orally active, non-peptide angiotensin II antagonists.	Abbott Laboratories